Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Gene Sets used for analysis in these studies. The first column is the Gene

From: Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance

GS ID # of Genes Gene Set Name
GS125959 2386 Cisplatin interacting with Homo sapiens associated genes (MeSH:D002945) in CTD
GS257116 883 GS257116: Cisplatin interacting with Mus musculus associated genes (MeSH:D002945) in CTD
GS263765 616 Cisplatin interacting with Rattus norvegicus associated genes (MeSH:D002945) in CTD
GS357326 378 Genes from CTD that interact with cisplatin and are conserved in human and mouse
GS357330 219 Genes from CTD that interact with cisplatin and are conserved in human and rat
GS357329 150 Genes from CTD that interact with cisplatin and are conserved in rat and mouse
GS271882 96 Genes from CTD that interact with cisplatin and are conserved in human, mouse and rat
GS237976 319 [MeSH] Cisplatin:D002945
GS271616 215 Genes upregulated in the BL1 subtype of triple negative breast cancer
GS271617 154 Genes upregulated in the BL2 subtype of triple negative breast cancer
GS271618 535 Genes upregulated in the IM subtype of triple negative breast cancer
GS271619 247 Genes upregulated in the M subtype of triple negative breast cancer
GS271621 805 Genes upregulated in LAR subtype of triple negative breast cancer
GS271724 829 Genes upregulated in the MSL subtype of triple negative breast cancer
GS271627 251 Genes downregulated in the BL1 subtype of triple negative breast cancer
GS271636 127 Genes downregulated in the BL2 subtype of triple negative breast cancer
GS271640 302 Genes downregulated in the IM subtype of triple negative breast cancer
GS271722 446 Genes downregulated in the M subtype of triple negative breast cancer
GS271729 382 Genes downregulated in the LAR subtype of triple negative breast cancer
GS271725 255 Genes downregulated in the MSL subtype of triple negative breast cancer